度他雄胺是首个也是惟一用于治疗前列腺增生的双重5d还原酶抑制剂,能够改善泌尿系统症状,降低急性尿潴留发作.坦索罗辛为α受体阻滞剂,能改善前列腺增生的症状.美国FDA的此次批准基于1项为期2年的多中心随机双盲对照的临床研究.纳入的患者为中度至重度前列腺增生男性患者(年龄≥50岁,前列腺体积(PV)≥30mLVIP中国新药...
Combodart、Duodart、Dutasteride/tamsulosin + [3] 靶点 5α-reductase x α1A-AR 作用机制 5α-reductase抑制剂(类固醇5α还原酶抑制剂)、α1A-AR拮抗剂(肾上腺素能受体α-1a拮抗剂) 治疗领域 泌尿生殖系统疾病 在研适应症 前列腺增生症 非在研适应症 ...
参考文献: Keating GM. Dutasteride/tamsulosin: in benign prostatic hyperplasia. Drugs Aging. 2012 May 1;29(5):405-19. doi: 10.2165/11208920-000000000-00000. PMID: 22550968.
度他雄胺与(dutasteride)坦索罗辛(tamsulosin)组合对良性前列腺增生有较好的效果 葛兰素史克(GSK)宣布,从度他雄胺和坦索罗辛联合治疗4年研究的最后结果,已发表在在线欧洲泌尿科学杂志上。 结果表明,Avodart和坦索罗辛联合治疗比单独使用坦索罗辛组显著降低了急性尿潴留(AUR)或前列腺增生症相关的手术风险(降低了66%,...
Jalyn (dutasteride / tamsulosin) for Benign Prostatic Hyperplasia"I was prescribed Jalyn for 8 months, and my doctor terminated its use at the start of the new year. I noticed very little improvement in the need to urinate approximately every two hours at night. I experienced feelings of weakn...
Dutasteride-Tamsulosin is a combination medication used for the treatment of benign prostatic hyperplasia.
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign ... Objective: To investigate the effect of combination therapy with dutasteride plus tamsulosin compared with each monotherapy on patient-reported he...
度他坦洛胶囊药品报告提供了度他坦洛胶囊的各种信息,包括度他坦洛胶囊的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
欧盟HMA上市药品数据库提供Dutasteride/Tamsulosin Sandoz 0,5 mg/0,4 mg hard capsules药品的基本信息,包括通用名dutasteride;tamsulosin hydrochloride,中文名度他雄胺;盐酸坦索罗辛,ATC代码G04CA52 tamsulosin and dutasteride以及上市许可持有人Sandoz Farmacéutica,
dutasteride and tamsulosin hydrochloride capsule Product Information Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1356 Route of AdministrationORAL Active Ingredient/Active Moiety Ingredient NameBasis of StrengthStrength DUTASTERIDE(UNII: O0J6XJN02I) (DUTASTERIDE - UNII:O0J6XJN02I)DUTAS...